ISRCTN34433361
Completed
Not Applicable
Double blinded, randomized, placebo-controlled trial to evaluate the efficacy of Stibium D6 on clotting in patients undergoing transurethral resection of the prostate (TURP)
niversity Clinic of Urology (Urologische Universitaetsklinik) (Switzerland)0 sites136 target enrollmentJuly 30, 2012
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Clinic of Urology (Urologische Universitaetsklinik) (Switzerland)
- Enrollment
- 136
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •2\. \>18 years
- •3\. Written informed consent
- •4\. Scheduled for transurethral resection of the prostate
Exclusion Criteria
- •1\. Peripheral artery occlusive disease
- •2\. Coronary hart disease
- •3\. Anticoagulation therapy (e.g. cumarines)
- •4\. History of stroke
- •5\. Clotting disorder
- •6\. Allergy / intolerance to Stibium D6
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Traditional Chinese medicine for the management of aromatase inhibitor-associated musculoskeletal symptomsISRCTN06129599Beijing Municipal Science and Technology Commission (China)84
Recruiting
Phase 2
A randomized, placebo-controlled, double blind trial to study the effects of Etidronate on ectopic CALCIfication in FAhr*s Disease or syndrome.Fahr's diseaseprimary familial brain calcification10007963NL-OMON53560niversitair Medisch Centrum Utrecht98
Completed
Phase 2
A randomized, placebo-controlled, double blind trial to investigate whether vitamin K2 can influence ongoing calcium deposition in patients with type 2 diabetesArterial calcificationcardiovascular disease10003216NL-OMON45148niversitair Medisch Centrum Utrecht70
Unknown
Not Applicable
Vitamin K and arterial calcificatioVitamin K, menaquinone-7, arterial calcification, dp-ucMGP, diabetes patiënts, arterial stiffness, bone metabolism.NL-OMON25255MC Utrecht
Active, not recruiting
Phase 1
Efficacy and safety of nintedanib in patients with PF-ILDEUCTR2015-003360-37-GBBoehringer Ingelheim Limited600